| Immune effector cell–associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes NG Holtzman, H Xie, S Bentzen, V Kesari, A Bukhari, F El Chaer, F Lutfi, ... Neuro-oncology 23 (1), 112-121, 2021 | 80 | 2021 |
| Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell–depleted lymphoma after CART therapy D Atanackovic, T Luetkens, D Omili, T Iraguha, F Lutfi, NM Hardy, X Fan, ... Blood, The Journal of the American Society of Hematology 140 (2), 152-156, 2022 | 30 | 2022 |
| The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma F Lutfi, NG Holtzman, AJ Kansagra, M Mustafa Ali, A Bukhari, J Yan, ... British Journal of Haematology 195 (3), 405-412, 2021 | 27 | 2021 |
| Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy S Dahiya, T Luetkens, F Lutfi, S Avila, T Iraguha, P Margiotta, KG Hankey, ... Blood advances 6 (2), 686-689, 2022 | 26 | 2022 |
| Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis M Shahzad, A Nguyen, A Hussain, M Ammad-Ud-Din, MS Faisal, E Tariq, ... Frontiers in Immunology 14, 1152457, 2023 | 23 | 2023 |
| Clinical predictors of delayed engraftment in autologous hematopoietic cell transplant recipients F Lutfi, WP Skelton IV, Y Wang, E Rosenau, N Farhadfar, H Murthy, ... Hematology/Oncology and Stem Cell Therapy 13 (1), 23-31, 2020 | 19 | 2020 |
| An interactive multimodality curriculum teaching medicine residents about oncologic documentation and billing A Patel, A Ali, F Lutfi, A Nwosu-Lheme, MJ Markham MedEdPORTAL 14, 10746, 2018 | 19 | 2018 |
| Chimeric antigen receptor T‐cell therapy after allogeneic stem cell transplant for relapsed/refractory large B‐cell lymphoma. F Lutfi, N Holtzman, J Siglin, A Bukhari, M Mustafa Ali, D Kim, ... British Journal of Haematology 192 (1), 2021 | 18 | 2021 |
| Targeting the CD27-CD70 pathway to improve outcomes in both checkpoint immunotherapy and allogeneic hematopoietic cell transplantation F Lutfi, L Wu, S Sunshine, X Cao Frontiers in Immunology 12, 715909, 2021 | 17 | 2021 |
| Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and review AA Mumtaz, A Fischer, F Lutfi, LR Matsumoto, D Atanackovic, ET Kolanci, ... British Journal of Ophthalmology 107 (7), 901-905, 2023 | 15 | 2023 |
| Low utility of the H-Score and HLH-2004 criteria to identify patients with secondary hemophagocytic lymphohistiocytosis after CAR-T cell therapy for relapsed/refractory diffuse … DW Kim, A Bukhari, F Lutfi, F Zafforoni, F Merechi, MK Mustafa Ali, ... Leukemia & Lymphoma 63 (6), 1339-1347, 2022 | 14 | 2022 |
| The effect of continued low dose aspirin therapy in patients undergoing percutaneous nephrolithotomy BJ Otto, RS Terry, FG Lutfi, JS Syed, HC Hamann, M Gupta, VG Bird The Journal of Urology 199 (3), 748-753, 2018 | 14 | 2018 |
| Agranulocytosis following COVID-19 recovery F Lutfi, A Benyounes, N Farrukh, J Bork, V Duong Cureus 12 (7), 2020 | 12 | 2020 |
| Deep dissection of the antiviral immune profile of patients with COVID-19 D Atanackovic, SV Avila, F Lutfi, D de Miguel-Perez, X Fan, ... Communications biology 4 (1), 1389, 2021 | 11 | 2021 |
| Real-world outcomes of brexucabtagene autoleucel (brexu-cel) for relapsed or refractory (R/R) adult B-cell acute lymphoblastic leukemia (B-cell ALL): evidence from the CIBMTR … E Bezerra, T Itani, K Wudhikarn, MA Perales, Y Yang, U Gergis, A Aribi, ... Blood 142, 1029, 2023 | 9 | 2023 |
| Hemophagocytic lymphohistiocytosis (HLH) presenting as fever of unknown origin and acute liver failure F Lutfi, A Patel, D Becker, M Shahid, K Shah IDCases 14, e00413, 2018 | 9 | 2018 |
| Imaging biomarkers to predict outcomes in patients with large B-cell lymphoma with a day 28 partial response by 18F-FDG PET/CT imaging following CAR-T therapy F Lutfi, O Goloubeva, A Kowatli, A Gryaznov, DW Kim, R Dureja, ... Clinical Lymphoma Myeloma and Leukemia 23 (10), 757-763, 2023 | 8 | 2023 |
| Anti-SARS-CoV-2 immune responses in patients receiving an allogeneic stem cell or organ transplant D Atanackovic, T Luetkens, SV Avila, NM Hardy, F Lutfi, G Sanchez-Petitto, ... Vaccines 9 (7), 737, 2021 | 8 | 2021 |
| Second-line treatment with CAR T-cell therapy for large B-cell lymphoma F Lutfi, A Patel, J Mehta, A Goyal, S Dahiya Clin Adv Hematol Oncol 21 (4), 170-178, 2023 | 6 | 2023 |
| Differences in the characteristics of younger and older MSI-H colorectal cancer (CRC) as determined by universal reflex testing. AJ Franke, WP Skelton, M Gaffar, F Lutfi, S Welniak, M Feely, JS Starr, ... Journal of Clinical Oncology 36 (15_suppl), 3593-3593, 2018 | 6 | 2018 |
